FSTL4

Model summary

A secreted, granule-stored extracellular antagonist that uses a Kazal inhibitory module, a calcium-sensitive EF-hand pair, and tandem immunoglobulin-like plus β-propeller scaffolds to bind and neutralize growth factors. By assembling high-avidity complexes that sequester trophic cues, it dampens downstream receptor signaling and thereby restrains dendritic spine maturation, axon formation, and collateral sprouting. Calcium binding modulates assembly and release from secretory granules, coupling stimulus-dependent secretion to extracellular growth-control.

Predicted Gene Ontology terms

1. 01

   I begin by dissecting the domain architecture.

   The N-terminal third contains a canonical Kazal-type protease inhibitor module: IPR036058 (Kazal domain superfamily, residues 65–133) encompasses IPR002350 (Kazal domain, residues 81–135). This compact disulfide-rich fold is classically used to block serine protease active sites and often doubles as a high-affinity ligand-binding scaffold. Immediately downstream lies a calcium-sensing core: IPR011992 (EF-hand domain pair, residues 171–257) includes IPR002048 (EF-hand domain, residues 174–209) and a defined Ca2+-coordination motif IPR018247 (EF-Hand 1, calcium-binding site, residues 187–199). This EF-hand pair confers Ca2+-dependent conformational control over adjacent binding modules. The central region is dominated by immunoglobulin-like scaffolding: IPR036179 (Immunoglobulin-like domain superfamily, residues 257–430) with internal repeats IPR013783 (Immunoglobulin-like fold, residues 258–334 and 335–430). Multiple Ig annotations—IPR007110 (Immunoglobulin-like domain, residues 251–338 and 341–426), IPR003599 (Immunoglobulin domain subtype, residues 255–338 and 347–431), and IPR003598 (Immunoglobulin subtype 2, residues 261–328 and 353–420)—together indicate tandem Ig-like domains that create an extended, rigid platform for protein–protein interactions. The C-terminal half transitions into a β-propeller-like scaffold: IPR015943 (WD40/YVTN repeat-like-containing domain superfamily, residues 497–783), with an additional Ig-like element IPR007110 (Immunoglobulin-like domain, residues 808–842). This β-propeller architecture typically mediates multivalent assembly and cargo selection. The entire assembly is captured by IPR050653 (Protease Inhibitors and Growth Factor Antagonists family, residues 62–781), which functionally unifies Kazal inhibition and growth-factor sequestration.

2. 02

   This ordered architecture dictates molecular function.

   The Kazal module provides a protease-inhibitory and ligand-binding surface; the EF-hand pair tunes affinity and specificity in response to Ca2+; and the tandem Ig-like plus WD40/YVTN propeller create a high-avidity binding platform. Such a composite scaffold is optimized for capturing extracellular growth factors rather than catalysis. The presence of a Kazal inhibitor fused to Ig-like and β-propeller domains is a hallmark of extracellular antagonists that neutralize morphogen signaling by direct sequestration. This causally supports GO:0019838 growth factor binding as the operative molecular function: the protein binds and neutralizes growth factors through multivalent, Ca2+-modulated interfaces.

3. 03

   From this binding activity, the biological processes follow.

   Sequestration of neurotrophic and morphogen signals attenuates synaptic maturation and neurite dynamics. By restraining trophic signaling, the architecture drives GO:0061000 negative regulation of dendritic spine development. The same inhibitory capture mechanism limits neurite branching and synaptic stabilization, aligning with GO:0050771 negative regulation of axonogenesis. In vascular and neural niches where collateral sprouting is triggered by local cues, growth-factor antagonism curbs inappropriate branching, consistent with GO:0048671 negative regulation of collateral sprouting. Together, these processes emerge directly from the protein’s growth-factor binding and inhibitory domain ensemble.

4. 04

   Cellular location is inferred from the secretion-competent architecture and storage logic.

   The EF-hand– and Ig-like–rich extracellular scaffold, together with the Kazal module, is characteristic of secreted antagonists that traffic through the regulated secretory pathway. The β-propeller and Ig-like repeats favor cargo clustering and vesicular sorting, pointing to packaging in secretory granules and stimulus-coupled release. This supports localization to GO:0030141 secretory granule and a soluble extracellular phase after exocytosis.

5. 05

   Mechanistically, I hypothesize that the protein is synthesized as a secreted precursor that is sorted into secretory granules via Ig/WD40-mediated multivalent interactions.

   Ca2+ binding to the EF-hand pair gates granule exocytosis and extracellular complex assembly. Upon secretion, the Kazal and Ig/WD40 surfaces cooperatively sequester growth factors, dampening downstream receptor signaling and thereby restraining dendritic spine maturation, axon formation, and collateral sprouting. Likely interaction partners include extracellular growth factors and their receptors: neurotrophins and their receptors (e.g., NGF/BDNF and Trk/NTRK complexes), heparan sulfate proteoglycans that concentrate secreted antagonists at the cell surface, and matrix-associated co-receptors that stabilize growth-factor–inhibitor assemblies. These interactions collectively implement a Ca2+-tuned extracellular brake on growth-factor pathways.